New instrumentation, reagents, and methods, as well as increasing interest in small and single-cell samples, could prove a boon for the technology.
The method combines stable isotope dimethyl labeling with DiLeu isobaric tagging and allows multiplexing of up to 24 samples in a single mass spec experiment.
The multiplexed proteomic approach could offer better sensitivity and accuracy than existing methods while working with a wider range of instrumentation.
The approach uses isobaric tagging to quantify proteins in single cells, and is one of the first to bring mass spec analysis to the single-cell level.
The company plans to use the money to speed its transition to a contract research business model, and to support its TMT reagents business.
The company hopes that looking at multiple species of the phosphorylated tau protein could allow for earlier and more accurate diagnosis of the disease.
The company, which has struggled to turn its broad proteomics expertise into steady profits, plans to focus more tightly on its pharma services business.
The firm is placing about 13.9 million new shares of its stock at 18 pence per share.
The UK-based proteomics and lipidomics firm will offer solutions to help healthcare professionals utilizing protein expression data in patient care.
Proteome Sciences this week lowered its full year 2014 guidance, citing delays in the timing of several contracts.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.